|Study Start Date:||
University of Rochester; Beth Israel Deaconess Medical Center
Phase 1 Trial of the Safety and Immunogenicity of an Oral, Replicating Ad26 Vectored HIV-1 Vaccine
A phase I double blind placebo-controlled clinical trial to evaluate the safety and immunogenicity of the combination of DNA-HIV-PT123 and AIDSVAX ® B/E in HIV-1-uninfected adult participants with or without underlying Schistosoma mansoni (S. mansoni) infection.
A Phase 1 Open-Labelled Trial to Evaluate the Safety and Immunogenicity of CN54gp140 in HIV-Uninfected, Healthy Volunteers.
ClinicalTrials.gov Identifier: NCT01966900